Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

The Oxytocin Receptor Gene (OXTR) Variant rs53576 Is Not Related to Emotional Traits or States in Young Adults.

Conner TS, McFarlane KG, Choukri M, Riordan BC, Flett JAM, Phipps-Green AJ, Topless RK, Merriman ME, Merriman TR.

Front Psychol. 2018 Dec 11;9:2548. doi: 10.3389/fpsyg.2018.02548. eCollection 2018.

2.

Topiramate-induced secondary angle closure: salient points in management.

Lam L, Wang N, Ormonde S, Merriman M.

Clin Exp Optom. 2018 Sep;101(5):704-706. doi: 10.1111/cxo.12685. Epub 2018 Apr 15. No abstract available.

PMID:
29656476
3.

Emergency department opioid pain medication prescribing: Influence of patient satisfaction and other factors.

Merriman MS, Acquisto NM, Nelson S, Jones CMC, Li T, McCann M, Adler DH.

Am J Emerg Med. 2018 May;36(5):896-897. doi: 10.1016/j.ajem.2017.09.039. Epub 2017 Sep 24. No abstract available.

PMID:
28967451
4.

Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ.

Allen RA, Brookings DC, Powell MJ, Delgado J, Shuttleworth LK, Merriman M, Fahy IJ, Tewari R, Silva JP, Healy LJ, Davies GCG, Twomey B, Cutler RM, Kotian A, Crosby A, McCluskey G, Watt GF, Payne A.

J Pharmacol Exp Ther. 2017 Jun;361(3):429-440. doi: 10.1124/jpet.116.237347. Epub 2017 Apr 25.

PMID:
28442583
5.

Inhibition of IKKβ Reduces Ethanol Consumption in C57BL/6J Mice.

Truitt JM, Blednov YA, Benavidez JM, Black M, Ponomareva O, Law J, Merriman M, Horani S, Jameson K, Lasek AW, Harris RA, Mayfield RD.

eNeuro. 2016 Oct 31;3(5). pii: ENEURO.0256-16.2016. eCollection 2016 Sep-Oct.

6.

A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.

Jamieson D, Griffin MJ, Sludden J, Drew Y, Cresti N, Swales K, Merriman M, Allen R, Bevan P, Buerkle M, Mala C, Coyle V, Rodgers L, Dean E, Greystoke A, Banerji U, Wilson RH, Evans TR, Anthoney A, Ranson M, Boddy AV, Plummer R.

Eur J Cancer. 2016 Nov;68:1-10. doi: 10.1016/j.ejca.2016.08.026. Epub 2016 Sep 28.

PMID:
27693888
7.

Localization of PPAR isotypes in the adult mouse and human brain.

Warden A, Truitt J, Merriman M, Ponomareva O, Jameson K, Ferguson LB, Mayfield RD, Harris RA.

Sci Rep. 2016 Jun 10;6:27618. doi: 10.1038/srep27618.

8.

Venlafaxine-induced intraocular pressure rise in a patient with open angle glaucoma.

Botha VE, Bhikoo R, Merriman M.

Clin Exp Ophthalmol. 2016 Nov;44(8):734-735. doi: 10.1111/ceo.12769. Epub 2016 May 29. No abstract available.

PMID:
27131226
9.

Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease.

Kienhorst LB, van Lochem E, Kievit W, Dalbeth N, Merriman ME, Phipps-Green A, Loof A, van Heerde W, Vermeulen S, Stamp LK, van Koolwijk E, de Graaf J, Holzinger D, Roth J, Janssens HJ, Merriman TR, Broen JC, Janssen M, Radstake TR.

Arthritis Rheumatol. 2015 Dec;67(12):3303-13. doi: 10.1002/art.39318.

10.

Selection of the Lowest Level for Fusion in Adolescent Idiopathic Scoliosis-A Systematic Review and Meta-Analysis.

Merriman M, Hu C, Noyes K, Sanders J.

Spine Deform. 2015 Mar;3(2):128-135. doi: 10.1016/j.jspd.2014.06.010. Epub 2015 Mar 4.

PMID:
27927303
11.

Tumor necrosis factor-α disruption of brain endothelial cell barrier is mediated through matrix metalloproteinase-9.

Wiggins-Dohlvik K, Merriman M, Shaji CA, Alluri H, Grimsley M, Davis ML, Smith RW, Tharakan B.

Am J Surg. 2014 Dec;208(6):954-60; discussion 960. doi: 10.1016/j.amjsurg.2014.08.014. Epub 2014 Sep 28.

PMID:
25312844
12.

Twenty-eight loci that influence serum urate levels: analysis of association with gout.

Phipps-Green AJ, Merriman ME, Topless R, Altaf S, Montgomery GW, Franklin C, Jones GT, van Rij AM, White D, Stamp LK, Dalbeth N, Merriman TR.

Ann Rheum Dis. 2016 Jan;75(1):124-30. doi: 10.1136/annrheumdis-2014-205877. Epub 2014 Sep 3.

PMID:
25187157
13.

A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.

Bossini-Castillo L, de Kovel C, Kallberg H, van 't Slot R, Italiaander A, Coenen M, Tak PP, Posthumus MD, Wijmenga C, Huizinga T, van der Helm-van Mil AH, Stoeken-Rijsbergen G, Rodriguez-Rodriguez L, Balsa A, González-Álvaro I, González-Gay MÁ, Gómez-Vaquero C, Franke B; LifeLines Cohort Study, Vermeulen S, van der Horst-Bruinsma Ie, Dijkmans BA, Wolbink GJ, Ophoff RA, Maehlen MT, van Riel P, Merriman M, Klareskog L, Lie BA, Merriman T, Crusius JB, Brouwer E, Martin J, de Vries N, Toes R, Padyukov L, Koeleman BP.

Ann Rheum Dis. 2015 Mar;74(3):e15. doi: 10.1136/annrheumdis-2013-204591. Epub 2014 Feb 14.

PMID:
24532677
14.

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.

Dalbeth N, House ME, Gamble GD, Pool B, Horne A, Purvis L, Stewart A, Merriman M, Cadzow M, Phipps-Green A, Merriman TR.

Arthritis Res Ther. 2014 Jan 30;16(1):R34. doi: 10.1186/ar4463.

15.

Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.

Flynn TJ, Phipps-Green A, Hollis-Moffatt JE, Merriman ME, Topless R, Montgomery G, Chapman B, Stamp LK, Dalbeth N, Merriman TR.

Arthritis Res Ther. 2013;15(6):R220.

16.

Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout.

Batt C, Phipps-Green AJ, Black MA, Cadzow M, Merriman ME, Topless R, Gow P, Harrison A, Highton J, Jones P, Stamp L, Dalbeth N, Merriman TR.

Ann Rheum Dis. 2014 Dec;73(12):2101-6. doi: 10.1136/annrheumdis-2013-203600. Epub 2013 Sep 11.

17.

Population-specific effects of SLC17A1 genotype on serum urate concentrations and renal excretion of uric acid during a fructose load.

Dalbeth N, House ME, Gamble GD, Horne A, Purvis L, Stewart A, Merriman M, Cadzow M, Phipps-Green A, Merriman TR.

Ann Rheum Dis. 2014 Jan;73(1):313-4. doi: 10.1136/annrheumdis-2013-203767. Epub 2013 Jul 12. No abstract available.

PMID:
23852697
18.

Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load.

Dalbeth N, House ME, Gamble GD, Horne A, Pool B, Purvis L, Stewart A, Merriman M, Cadzow M, Phipps-Green A, Merriman TR.

Ann Rheum Dis. 2013 Nov;72(11):1868-73. doi: 10.1136/annrheumdis-2012-202732. Epub 2013 Jan 24.

PMID:
23349133
19.

Ocular trauma epidemiology: 10-year retrospective study.

Pandita A, Merriman M.

N Z Med J. 2012 Jan 20;125(1348):61-9.

PMID:
22282278
20.

Fused thiophene derivatives as MEK inhibitors.

Laing VE, Brookings DC, Carbery RJ, Simorte JG, Hutchings MC, Langham BJ, Lowe MA, Allen RA, Fetterman JR, Turner J, Meier C, Kennedy J, Merriman M.

Bioorg Med Chem Lett. 2012 Jan 1;22(1):472-5. doi: 10.1016/j.bmcl.2011.10.105. Epub 2011 Nov 6.

PMID:
22119475
21.

Replication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample sets.

Chen-Xu M, Topless R, McKinney C, Merriman ME, Phipps-Green A, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Nissen M, Smith MD, van Rij A, Jones GT, Rodriguez-Rodriguez L, Fernandez-Gutierrez B, Teruel M, Balsa A, Pascual-Salcedo D, Ortiz AM, Gonzalez-Gay MA, Steer S, Maehlen M, Lie B, Wordsworth BP, Stamp LK, Martin J, Merriman TR.

Ann Rheum Dis. 2012 Jan;71(1):155-7. doi: 10.1136/annrheumdis-2011-200591. Epub 2011 Sep 16. No abstract available.

PMID:
21926184
22.

Analysis of association of DNASE2 promoter variation with rheumatoid arthritis in European Caucasians.

Phipps-Green A, McKinney C, Rossol M, Merriman ME, Topless R, Hollis-Moffatt JE, Wan Taib WR, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Wanger U, Wordsworth P, Merriman TR.

Ann Rheum Dis. 2011 Aug;70(8):1512-4. doi: 10.1136/ard.2010.138727. Epub 2011 Feb 12. No abstract available.

PMID:
21317435
23.

The PTPN22 locus and rheumatoid arthritis: no evidence for an effect on risk independent of Arg620Trp.

Wan Taib WR, Smyth DJ, Merriman ME, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp L, Steer S, Todd JA, Merriman TR.

PLoS One. 2010 Oct 21;5(10):e13544. doi: 10.1371/journal.pone.0013544.

24.

A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation.

Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, Steer S, Merriman TR, Vyse TJ.

PLoS Med. 2010 Sep 21;7(9):e1000341. doi: 10.1371/journal.pmed.1000341.

25.

A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets.

Phipps-Green AJ, Hollis-Moffatt JE, Dalbeth N, Merriman ME, Topless R, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Merriman TR.

Hum Mol Genet. 2010 Dec 15;19(24):4813-9. doi: 10.1093/hmg/ddq412. Epub 2010 Sep 21.

PMID:
20858603
26.

Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.

McKinney C, Fanciulli M, Merriman ME, Phipps-Green A, Alizadeh BZ, Koeleman BP, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Steer S, Barrera P, Coenen MJ, Franke B, van Riel PL, Vyse TJ, Aitman TJ, Radstake TR, Merriman TR.

Ann Rheum Dis. 2010 Sep;69(9):1711-6. doi: 10.1136/ard.2009.123588. Epub 2010 May 14.

27.

Adaptation, dissemination, and evaluation of a cancer palliative care curriculum for the Indian health system.

Arenella C, Finke B, Domer T, Kaur JS, Merriman MP, Ousley A.

J Palliat Care. 2010 Spring;26(1):15-21.

PMID:
20402180
28.

Learning that leads to action: impact and characteristics of a professional education approach to improve the care of critically ill children and their families.

Solomon MZ, Browning DM, Dokken DL, Merriman MP, Rushton CH.

Arch Pediatr Adolesc Med. 2010 Apr;164(4):315-22. doi: 10.1001/archpediatrics.2010.12.

PMID:
20368484
29.

Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets.

Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Merriman TR.

Arthritis Rheum. 2009 Nov;60(11):3485-92. doi: 10.1002/art.24938.

30.

The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets.

Hollis-Moffatt JE, Rowley KA, Phipps-Green AJ, Merriman ME, Dalbeth N, Gow P, Harrison AA, Highton J, Jones PB, Stamp LK, Harrison P, Wordsworth BP, Merriman TR.

Arthritis Res Ther. 2009;11(5):R152. doi: 10.1186/ar2828. Epub 2009 Oct 9.

31.

No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population.

Phipps-Green AJ, Topless RK, Merriman ME, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, Stamp LK, Harrison P, Wordsworth BP, Merriman TR.

Rheumatology (Oxford). 2009 Dec;48(12):1614-5. doi: 10.1093/rheumatology/kep254. Epub 2009 Sep 11. No abstract available.

PMID:
19748962
32.

Therapeutic benefits of expressive writing in an electronic format.

Atkinson R, Hare T, Merriman M, Vogel A.

Nurs Adm Q. 2009 Jul-Sep;33(3):212-5. doi: 10.1097/NAQ.0b013e3181accabc.

PMID:
19546740
33.

Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.

Hollis-Moffatt JE, Merriman ME, Rodger RA, Rowley KA, Chapman PT, Dalbeth N, Gow PJ, Harrison AA, Highton J, Jones PB, O'Donnell JL, Stamp LK, Merriman TR.

Ann Rheum Dis. 2009 Aug;68(8):1340-4. doi: 10.1136/ard.2008.090142. Epub 2008 Jul 22.

PMID:
18647855
34.

4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase.

Alexander R, Balasundaram A, Batchelor M, Brookings D, Crépy K, Crabbe T, Deltent MF, Driessens F, Gill A, Harris S, Hutchinson G, Kulisa C, Merriman M, Mistry P, Parton T, Turner J, Whitcombe I, Wright S.

Bioorg Med Chem Lett. 2008 Aug 1;18(15):4316-20. doi: 10.1016/j.bmcl.2008.06.076. Epub 2008 Jun 28.

PMID:
18625552
35.

Pre-hospital discharge planning: empowering elderly patients through choice.

Merriman ML.

Crit Care Nurs Q. 2008 Jan-Mar;31(1):52-8. doi: 10.1097/01.CNQ.0000306397.25024.d6. Review.

PMID:
18316937
36.

Next of kin perspectives on the experience of end-of-life care in a community setting.

Norris K, Merriman MP, Curtis JR, Asp C, Tuholske L, Byock IR.

J Palliat Med. 2007 Oct;10(5):1101-15.

PMID:
17985967
37.

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR.

Ann Rheum Dis. 2008 Mar;67(3):409-13. Epub 2007 Jun 29.

PMID:
17604289
38.

Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association.

Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR.

J Clin Endocrinol Metab. 2007 Mar;92(3):1106-11. Epub 2007 Jan 2.

PMID:
17200162
39.

Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis.

Steer S, Abkevich V, Gutin A, Cordell HJ, Gendall KL, Merriman ME, Rodger RA, Rowley KA, Chapman P, Gow P, Harrison AA, Highton J, Jones PB, O'Donnell J, Stamp L, Fitzgerald L, Iliev D, Kouzmine A, Tran T, Skolnick MH, Timms KM, Lanchbury JS, Merriman TR.

Genes Immun. 2007 Jan;8(1):57-68. Epub 2006 Dec 7.

PMID:
17159887
40.

Peer-professional workgroups in palliative care: a strategy for advancing professional discourse and practice.

Byock I, Twohig JS, Merriman M, Collins K.

J Palliat Med. 2006 Aug;9(4):934-47.

PMID:
16910808
41.

QAPI: a new way to manage hospice quality.

Merriman MP, Tecca M, Wilson HP.

Caring. 2006 Feb;25(2):34-40. No abstract available.

PMID:
16579283
42.

Promoting excellence in end-of-life care: a report on innovative models of palliative care.

Byock I, Twohig JS, Merriman M, Collins K.

J Palliat Med. 2006 Feb;9(1):137-51.

PMID:
16430353
43.

Association of the PTPN22 locus with rheumatoid arthritis in a New Zealand Caucasian cohort.

Simkins HM, Merriman ME, Highton J, Chapman PT, O'Donnell JL, Jones PB, Gow PJ, McLean L, Pokorny V, Harrison AA, Merriman TR.

Arthritis Rheum. 2005 Jul;52(7):2222-5. No abstract available.

44.

End-of-life treatment preferences of persons with serious mental illness.

Foti ME, Bartels SJ, Van Citters AD, Merriman MP, Fletcher KE.

Psychiatr Serv. 2005 May;56(5):585-91.

PMID:
15872168
45.

Medical advance care planning for persons with serious mental illness.

Foti ME, Bartels SJ, Merriman MP, Fletcher KE, Van Citters AD.

Psychiatr Serv. 2005 May;56(5):576-84.

PMID:
15872167
46.

Evaluation of the Missoula-VITAS Quality of Life Index--revised: research tool or clinical tool?

Schwartz CE, Merriman MP, Reed G, Byock I.

J Palliat Med. 2005 Feb;8(1):121-35.

PMID:
15662181
47.

Cystoid macular oedema with trypan blue use.

Gouws P, Merriman M, Goethals S, Simcock PR, Greenwood RJ, Wright G.

Br J Ophthalmol. 2004 Oct;88(10):1348-9. No abstract available.

48.

Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.

Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A, Highton J, McLean L.

Ann Rheum Dis. 2005 Mar;64(3):487-90. Epub 2004 Aug 26.

49.
50.

The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune disease.

Hall RJ, Merriman ME, Green RA, Markham VH, Smyth DJ, Heward JM, Jennings CE, Braithwaite AW, Cundy T, Darlow BA, Gow PJ, Harrison AA, Highton J, Hunt PJ, Manning P, Pokorny V, Scott RS, Taylor BJ, Willis JA, Yeoman S, McLean L, Gough SC, Pearce SH, Merriman TR.

Eur J Hum Genet. 2003 Nov;11(11):840-4.

Supplemental Content

Loading ...
Support Center